Skin Manifestations of Internal Diseases and Dermatological Pharmaceuticals

The skin serves as a mirror to internal diseases, often manifesting systemic conditions through distinct dermatological signs. This review explores the cutaneous manifestations of internal diseases such as diabetes, lupus, liver disorders, and malignancies, emphasizing their diagnostic and prognostic significance. Additionally, it evaluates the role of dermatological pharmaceuticals in managing these conditions, focusing on topical and systemic treatments, biologics, and emerging therapies. The interplay between systemic diseases and skin manifestations necessitates a multidisciplinary approach for accurate diagnosis and effective treatment. This article highlights key clinical presentations, underlying pathophysiological mechanisms, and therapeutic advancements, providing a comprehensive resource for clinicians and researchers. Keywords: Skin manifestations, internal diseases, dermatological pharmaceuticals, systemic lupus erythematosus, diabetes mellitus, biologics, cutaneous markers.